191 related articles for article (PubMed ID: 33869290)
1. Management and Prognosis of Interstitial Lung Disease With Lung Cancer (ILD-LC): A Real-World Cohort From Three Medical Centers in China.
Xiaohong X; Liqiang W; Na L; Xinqing L; Yinyin Q; Ming L; Ming O; Qian H; Qun L; Shiyue L; Chunyan L; Xiaoqian W; Shuanying Y; Wei H; Mei L; Ping W; Chengzhi Z
Front Mol Biosci; 2021; 8():660800. PubMed ID: 33869290
[TBL] [Abstract][Full Text] [Related]
2. Impact of idiopathic pulmonary fibrosis on advanced non-small cell lung cancer survival.
Kanaji N; Tadokoro A; Kita N; Murota M; Ishii T; Takagi T; Watanabe N; Tojo Y; Harada S; Hasui Y; Kadowaki N; Bandoh S
J Cancer Res Clin Oncol; 2016 Aug; 142(8):1855-65. PubMed ID: 27350261
[TBL] [Abstract][Full Text] [Related]
3. Clinical spectrum of Chinese hospitalized lung cancer patients with concomitant interstitial lung disease: before and after the new era of LC treatment.
Chen R; Shao C; Liu X; Huang H; Pan B; Xu K; Zhu R; Li M; Zhao Y; Chen K; Wang M; Xu Z
Clin Exp Med; 2023 Oct; 23(6):2321-2330. PubMed ID: 36715832
[TBL] [Abstract][Full Text] [Related]
4. Glasgow Prognostic Score predicts chemotherapy-triggered acute exacerbation-interstitial lung disease in patients with non-small cell lung cancer.
Kikuchi R; Takoi H; Tsuji T; Nagatomo Y; Tanaka A; Kinoshita H; Ono M; Ishiwari M; Toriyama K; Kono Y; Togashi Y; Yamaguchi K; Yoshimura A; Abe S
Thorac Cancer; 2021 Mar; 12(5):667-675. PubMed ID: 33480111
[TBL] [Abstract][Full Text] [Related]
5. Comparison of clinical courses and mortality of connective tissue disease-associated interstitial pneumonias and chronic fibrosing idiopathic interstitial pneumonias.
Yıldırım F; Türk M; Bitik B; Erbaş G; Köktürk N; Haznedaroğlu Ş; Türktaş H
Kaohsiung J Med Sci; 2019 Jun; 35(6):365-372. PubMed ID: 30913371
[TBL] [Abstract][Full Text] [Related]
6. Idiopathic pulmonary fibrosis in small cell lung cancer as a predictive factor for poor clinical outcome and risk of its exacerbation.
Koyama N; Iwai Y; Nagai Y; Aoshiba K; Nakamura H
PLoS One; 2019; 14(8):e0221718. PubMed ID: 31442290
[TBL] [Abstract][Full Text] [Related]
7. [Surgical Treatment of Lung Cancer Combined with Interstitial Lung Disease].
Huang C; Ma C; Wu Q; Jiao P; Sun Y; Tian W; Yu H; Huang W; Wang Y; Tong H
Zhongguo Fei Ai Za Zhi; 2020 May; 23(5):343-350. PubMed ID: 32429636
[TBL] [Abstract][Full Text] [Related]
8. Interstitial Lung Disease Associated with Lung Cancer: A Case-Control Study.
Gibiot Q; Monnet I; Levy P; Brun AL; Antoine M; Chouaïd C; Cadranel J; Naccache JM
J Clin Med; 2020 Mar; 9(3):. PubMed ID: 32150840
[TBL] [Abstract][Full Text] [Related]
9. [The clinical features and prognosis of interstitial lung disease patients with positive anti-neutrophil cytoplasmic antibody].
Gao C; Sun X; Huang J; Peng M; Sun XF; Zhang T; Shi JH
Zhonghua Jie He He Hu Xi Za Zhi; 2020 Apr; 43(4):362-368. PubMed ID: 32294819
[No Abstract] [Full Text] [Related]
10. Real world data of combined lung cancer and interstitial lung disease.
Kawahara T; Sakashita H; Suzuki T; Tateishi T; Miyazaki Y
J Thorac Dis; 2019 Oct; 11(10):4144-4151. PubMed ID: 31737297
[TBL] [Abstract][Full Text] [Related]
11. [Retrospective analysis and a cross-sectional questionnaire survey of lung cancer concomitant with interstitial lung disease].
Liu XN; Li J; Chen RX; Shao C; Huang H; Xu X; Zhang MZ; Wang ZJ; Xu Z
Zhonghua Jie He He Hu Xi Za Zhi; 2022 Dec; 45(12):1192-1198. PubMed ID: 36480849
[No Abstract] [Full Text] [Related]
12. Chemotherapy-associated Acute Exacerbation of Interstitial Lung Disease Shortens Survival Especially in Small Cell Lung Cancer.
Nakao S; Yamaguchi K; Sakamoto S; Horimasu Y; Masuda T; Miyamoto S; Nakashima T; Iwamoto H; Fujitaka K; Hamada H; Hattori N
Anticancer Res; 2019 Oct; 39(10):5725-5731. PubMed ID: 31570474
[TBL] [Abstract][Full Text] [Related]
13. Impact of Interstitial Lung Disease Classification on the Development of Acute Exacerbation of Interstitial Lung Disease and Prognosis in Patients with Stage III Non-Small-Cell Lung Cancer and Interstitial Lung Disease Treated With Chemoradiotherapy.
Kobayashi H; Naito T; Omae K; Omori S; Nakashima K; Wakuda K; Ono A; Kenmotsu H; Murakami H; Endo M; Harada H; Takahashi T
J Cancer; 2018; 9(11):2054-2060. PubMed ID: 29896291
[No Abstract] [Full Text] [Related]
14. Outcomes after lobar versus sublobar resection for clinical stage I non-small cell lung cancer in patients with interstitial lung disease.
Tsutani Y; Mimura T; Kai Y; Ito M; Misumi K; Miyata Y; Okada M
J Thorac Cardiovasc Surg; 2017 Sep; 154(3):1089-1096.e1. PubMed ID: 28483268
[TBL] [Abstract][Full Text] [Related]
15. The clinicopathological study of lung cancer concealed in end-stage of interstitial lung disease.
Wang B; Zhang X; Chen H; Yang L; Li J; Xiao F; Liang C; Zhong D
Transl Cancer Res; 2020 Feb; 9(2):536-546. PubMed ID: 35117398
[TBL] [Abstract][Full Text] [Related]
16. Glasgow prognostic score for prediction of chemotherapy-triggered acute exacerbation interstitial lung disease in patients with small cell lung cancer.
Kikuchi R; Takoi H; Tsuji T; Nagatomo Y; Tanaka A; Kinoshita H; Ono M; Ishiwari M; Toriyama K; Kono Y; Togashi Y; Yamaguchi K; Yoshimura A; Abe S
Thorac Cancer; 2021 Jun; 12(11):1681-1689. PubMed ID: 33939332
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for progression and prognosis of rheumatoid arthritis-associated interstitial lung disease: single center study with a large sample of Chinese population.
Fu Q; Wang L; Li L; Li Y; Liu R; Zheng Y
Clin Rheumatol; 2019 Apr; 38(4):1109-1116. PubMed ID: 30535993
[TBL] [Abstract][Full Text] [Related]
18. Outcome following nivolumab treatment in patients with advanced non-small cell lung cancer and comorbid interstitial lung disease in a real-world setting.
Assié JB; Chouaïd C; Nunes H; Reynaud D; Gaudin AF; Grumberg V; Jolivel R; Jouaneton B; Cotté FE; Duchemann B
Ther Adv Med Oncol; 2023; 15():17588359231152847. PubMed ID: 36743523
[TBL] [Abstract][Full Text] [Related]
19. Peripheral-type small cell lung cancer is associated with better survival and higher frequency of interstitial lung disease.
Kanaji N; Sakai K; Ueda Y; Miyawaki H; Ishii T; Watanabe N; Kita N; Kadota K; Kadowaki N; Bandoh S
Lung Cancer; 2017 Jun; 108():126-133. PubMed ID: 28625624
[TBL] [Abstract][Full Text] [Related]
20. Lung cancer in connective tissue disease-associated interstitial lung disease: clinical features and impact on outcomes.
Watanabe S; Saeki K; Waseda Y; Murata A; Takato H; Ichikawa Y; Yasui M; Kimura H; Hamaguchi Y; Matsushita T; Yamada K; Kawano M; Furuichi K; Wada T; Kasahara K
J Thorac Dis; 2018 Feb; 10(2):799-807. PubMed ID: 29607151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
